SCHEMBL3701966

SCHEMBL3701966

Cc1cc(C)n2nc(NC(=O)Cc3ccc(Cl)cc3)c(-c3ccc(C(F)(F)F)cc3)c2n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNQ3 O43525 4/20 0.56
KCNQ2 O43526 4/20 0.56
HTT P42858 1/20 0.45
NR2E1 Q9Y466 1/20 0.45
CSNK1D P48730 1/20 0.45
MAPT P10636 3/20 0.43
KDM4E B2RXH2 2/20 0.43
POLB P06746 2/20 0.43
HPGD P15428 2/20 0.43
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
KMT2A Q03164 1/20 0.43
ATM Q13315 1/20 0.43
CNR2 P34972 1/20 0.42
LMNA P02545 1/20 0.42
TP53 P04637 1/20 0.42
P2RY14 Q15391 1/20 0.42
CYP1A1 P04798 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PSD A5PKW4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3695035 0.80 KCNQ3 (0.55) KCNQ3KCNQ2MAPTKDM4EPOLB
SCHEMBL3703612 0.79 KCNQ3 (0.77) KCNQ3KCNQ2KDM4EPOLB
SCHEMBL3704032 0.78 KCNQ3 (0.77) KCNQ3KCNQ2MAPTKDM4EPOLB
SCHEMBL3700117 0.77 KCNQ3 (0.79) KCNQ3KCNQ2MAPTKDM4EPOLB
SCHEMBL3706555 0.76 KCNQ3 (0.49) KCNQ3KCNQ2CSNK1DMAPTKDM4E
SCHEMBL3702148 0.73 KCNQ3 (0.52) KCNQ3KCNQ2NR2E1MAPTKDM4E
SCHEMBL3707943 0.73 KCNQ3 (0.43) KCNQ3KCNQ2MAPTKDM4EHPGD
SCHEMBL3698696 0.73 RECQL (0.51) KCNQ3KCNQ2HTTCSNK1DKDM4E
SCHEMBL3706186 0.72 KCNQ3 (0.57) KCNQ3KCNQ2HTTMAPTKDM4E
SCHEMBL3706845 0.72 KCNQ3 (1.00) KCNQ3KCNQ2KDM4EPOLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8609669-B2 Potassium channel modulators ABBVIE INC. (US) 2013-12-17 US claimed
US-20120122888-A1 Potassium Channel Modulators ABBOTT LABORATORIES (US) 2012-05-17 US claimed
US-8609669-B2 Potassium channel modulators ABBVIE INC. (US) 2013-12-17 US disclosed
WO-2012067822-A1 PYRAZOLO [1, 5 -A] PYRIMIDIN POTASSIUM CHANNEL MODULATORS ABBOTT LABORATORIES (US) 2012-05-24 WO disclosed
US-20120122888-A1 Potassium Channel Modulators ABBOTT LABORATORIES (US) 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122888-A1 Potassium Channel Modulators KCNQ1, KCNQ2, KCNJ2 KCNQ3 4/4885KCNQ2 2/4885HTT 1789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.